美亞控股(01116.HK)與顧問訂立技術諮詢協議 於中國農業產業應用納米PCM
美亞控股(01116.HK)公佈,於今年8月30日,其間接非全資附屬公司廣州美亞與顧問訂立技術諮詢協議,據此,顧問將就於中國農業產業應用納米PCM向廣州美亞提供諮詢服務,年期由當日起至明年8月29日止。
集團指,廣州美亞透過其直接全資附屬公司廣州美亞科技發展有限公司,獲授予於中國生產納米PCM之獨家權利,可廣泛應用於伺服器機房、醫療、公共建築、機場、鐵路運輸、酒店、大型工業及其他領域之空調、製冷及供暖系統。董事會認爲,顧問憑藉其於中國農業領域之政府權力,能夠有效促進及加強納米PCM於農業領域之應用及使用,從而有助集團把握市場機遇、拓展其於中國之環保技術相關業務、進一步增強其業務組合,併爲公司及股東整體帶來額外回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.